Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, July 29, 2022
[ Fri, Jul 29th 2022
] - WOPRAI
[ Fri, Jul 29th 2022
] - WOPRAI
[ Fri, Jul 29th 2022
] - WOPRAI
[ Fri, Jul 29th 2022
] - WOPRAI
[ Fri, Jul 29th 2022
] - WOPRAI
[ Fri, Jul 29th 2022
] - WOPRAI
[ Fri, Jul 29th 2022
] - WOPRAI
[ Fri, Jul 29th 2022
] - WOPRAI
[ Fri, Jul 29th 2022
] - WOPRAI
[ Fri, Jul 29th 2022
] - WOPRAI
[ Fri, Jul 29th 2022
] - WOPRAI
[ Fri, Jul 29th 2022
] - WOPRAI
[ Fri, Jul 29th 2022
] - WOPRAI
[ Fri, Jul 29th 2022
] - WOPRAI
[ Fri, Jul 29th 2022
] - WOPRAI
[ Fri, Jul 29th 2022
] - WOPRAI
[ Fri, Jul 29th 2022
] - WOPRAI
[ Fri, Jul 29th 2022
] - WOPRAI
[ Fri, Jul 29th 2022
] - WOPRAI
[ Fri, Jul 29th 2022
] - WOPRAI
[ Fri, Jul 29th 2022
] - WOPRAI
[ Fri, Jul 29th 2022
] - WOPRAI
[ Fri, Jul 29th 2022
] - WOPRAI
[ Fri, Jul 29th 2022
] - WOPRAI
[ Fri, Jul 29th 2022
] - WOPRAI
[ Fri, Jul 29th 2022
] - WOPRAI
[ Fri, Jul 29th 2022
] - WOPRAI
[ Fri, Jul 29th 2022
] - WOPRAI
[ Fri, Jul 29th 2022
] - WOPRAI
[ Fri, Jul 29th 2022
] - WOPRAI
Bradley Canino Maintained (ZNTL) at Strong Buy with Decreased Target to $70 on, Jul 29th, 2022
Bradley Canino of Stifel, Maintained "Zentalis Pharmaceuticals, Inc." (ZNTL) at Strong Buy with Decreased Target from $72 to $70 on, Jul 29th, 2022.
Bradley has made no other calls on ZNTL in the last 4 months.
There are 4 other peers that have a rating on ZNTL. Out of the 4 peers that are also analyzing ZNTL, 0 agree with Bradley's Rating of Hold.
These are the ratings of the 4 analyists that currently disagree with Bradley
- Tyler Van Buren of "Cowen & Co." Initiated at Buy on, Tuesday, July 12th, 2022
- Matthew Biegler of "Oppenheimer" Maintained at Buy with Decreased Target to $85 on, Tuesday, April 12th, 2022
- Andrew Berens of "SVB Leerink" Maintained at Buy with Decreased Target to $67 on, Tuesday, April 12th, 2022
- Derek Archila of "Wells Fargo" Initiated at Buy and Held Target at $67 on, Wednesday, April 6th, 2022
